Maryam Emadzadeh; Seyed Mostafa Parizadeh; Reza Jafarzadeh-Esfehani; Reza Sahebi; Ramin Sadeghi; Gordon A. Ferns; Majid Ghayour-Mobarhan
Abstract
Objectives: Various fortification strategies have been proposed to account to treat or prevent vitamin D deficiency. However, the optimum fortification approach, and the effect of these on health is not widely understood. There have been controversial reports regarding the effect of vitamin D fortification ...
Read More
Objectives: Various fortification strategies have been proposed to account to treat or prevent vitamin D deficiency. However, the optimum fortification approach, and the effect of these on health is not widely understood. There have been controversial reports regarding the effect of vitamin D fortification on the lipid profile. The aim of present review is the evaluation of administration of vitamin D fortified products on lipid profile.Methods: We used databases including PubMed/Medline, ISI Web of Knowledge, Science Direct, Scopus and Cochrane Library. A search was conducted until 2020 Randomized controlled trials that have assessed the relationship between consumption of vitamin D fortified products and serum lipid profile were included. The relationship between fortification dose, dairy or non-dairy fortification as well as duration of intervention and plasma lipid profiles evaluated in separate sub-groups.Results: Among serum lipids including total cholesterol(TC), triglyceride(TG), low density lipoprotein(LDL) and high density lipoprotein(HDL), fortification of vitamin D was reported to have a significant effect on reducing total cholesterol (pooled estimate: -0.089 mmol/L, 95%CI: -0.134 to -0.044, p<0.001). Its effect on other lipid profiles were not significant (LDL pooled estimate:-0.115 mmol/L, 95%CI:-0.238 to 0.008; HDL pooled estimate:0.024 mmol/L, 95%CI:-0.024 to 0.071; TG pooled estimate:-0.176mmol/L, 95%CI:-0.499 to 0.148).Conclusion: This meta-analysis demonstrated that vitamin D fortification could significantly reduce TC both in long and short term interventions and in different products. However this reduction, whilst statistically significant, may not be clinically important. The effect of fortification on other lipid profile components vary depending on dose and duration.
Milad Ashrafizadeh; Zahra Ahmadi
Abstract
Statins are the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A, which are extensively used to decrease the concentration of cholesterol in patients with hyperlipidemia. Statins are divided into two categories based on their own unique properties. Considering the pleiotropic effects of statins, they ...
Read More
Statins are the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A, which are extensively used to decrease the concentration of cholesterol in patients with hyperlipidemia. Statins are divided into two categories based on their own unique properties. Considering the pleiotropic effects of statins, they are applied as antioxidant, anti-inflammatory, anti-thrombotic, immunomodulatory, and plaque-stabilizing agents. In addition, statins affect the diversity and population of gut microbiota, which is a complicated microbial community remarkably involved in the regulation of metabolic responses, immune system, and human health. This community is also associated with age-related health problems, allergy, asthma, and inflammatory intestinal diseases. Therefore, evaluation of the interactions between statins and gut microbiota is essential to predicting the outcomes of these agents. The present study aimed to review the properties and pleiotropic effects of statins. Furthermore, the role of gut microbiota in health was discussed, and the significant effects of statins on gut microbiota and their interactions were described based on clinical and animal studies.